In line with this, myeloma-associated non-canonical genomic aberrations may reinforce pro-survival TNF-mediated NF-κB activity through autoregulatory RelB control and thereby exacerbate the disease [102]. This evidence concerns the gene NFKB1 and plasma cell myeloma.